INOVIQ Ltd (ASX:IIQ)
0.4000
0.00 (0.00%)
Aug 25, 2025, 3:00 PM AEST
INOVIQ Revenue
In the fiscal year ending June 30, 2025, INOVIQ had annual revenue of 1.82M AUD with 16.25% growth. INOVIQ had revenue of 986.88K in the half year ending June 30, 2025, a decrease of -28.84%.
Revenue
1.82M
Revenue Growth
+16.25%
P/S Ratio
24.60
Revenue / Employee
121.02K
Employees
15
Market Cap
44.65M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 1.82M | 253.75K | 16.25% |
Jun 30, 2024 | 1.56M | 10.36K | 0.67% |
Jun 30, 2023 | 1.55M | -446.01K | -22.33% |
Jun 30, 2022 | 2.00M | 726.44K | 57.16% |
Jun 30, 2021 | 1.27M | 735.67K | 137.48% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.00B |
Mesoblast | 9.16M |